SCHEMBL4835181

SCHEMBL4835181

O=c1c2cc3c(=O)n(OS(=O)(=O)c4ccc(Br)cc4)c(=O)c3cc2c(=O)n1OS(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
MMP2 P08253 3/20 0.39
CA2 P00918 7/20 0.38
CA1 P00915 5/20 0.38
CA9 Q16790 5/20 0.38
CA12 O43570 4/20 0.38
PLCG1 P19174 1/20 0.37
FEN1 P39748 1/20 0.36
MMP1 P03956 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
PARL Q9H300 2/20 0.35
VDR P11473 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829876 0.84 KMT2A (0.50) KDM4EALDH1A1MAPTHPGDMMP2
SCHEMBL4836943 0.83 CA1 (0.38) KDM4EALDH1A1MAPTHPGDMMP2
SCHEMBL12534653 0.83 CA2 (0.41) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL4835154 0.83 VDR (0.53) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL4836742 0.83 ALDH1A1 (0.46) KDM4EALDH1A1HPGDMMP2CA2
SCHEMBL4826493 0.82 PARL (0.53) KDM4EALDH1A1MAPTHPGDCA2
SCHEMBL12534680 0.82 CA12 (0.42) THRBKDM4EALDH1A1LMNAMAPT
SCHEMBL4834642 0.80 GAA (0.48) LMNAMMP2CA2CA1CA9
SCHEMBL4829946 0.79 VDR (0.55) KDM4EALDH1A1MAPTCA2CA1
SCHEMBL4826553 0.79 TDP1 (0.43) KDM4EALDH1A1MAPTHPGDCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 THRB 3022/4885KDM4E 2501/4885ALDH1A1 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.